Integrated Pharmaceuticals Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Integrated Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Integrated Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Integrated Pharmaceuticals is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Integrated |
Integrated Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Integrated Pharmaceuticals on October 21, 2025 and sell it today you would earn a total of 100.00 from holding Integrated Pharmaceuticals or generate -100.0% return on investment over 90 days. Integrated Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Integrated, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Integrated Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Integrated Pharmaceuticals, and traders can use it to determine the average amount a Integrated Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| INTP |
Based on monthly moving average Integrated Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Pharmaceuticals by adding Integrated Pharmaceuticals to a well-diversified portfolio.
Integrated Pharmaceuticals Fundamentals Growth
Integrated Stock prices reflect investors' perceptions of the future prospects and financial health of Integrated Pharmaceuticals, and Integrated Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integrated Stock performance.
| Return On Equity | -1.91 | |||
| Return On Asset | -0.57 | |||
| Operating Margin | (42.29) % | |||
| Current Valuation | (180.81 K) | |||
| Price To Earning | (0.06) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 35.4 K | |||
| EBITDA | (594.13 K) | |||
| Cash And Equivalents | 180.85 K | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Total Asset | 1.11 M | |||
| Current Asset | 358 K | |||
| Current Liabilities | 357 K | |||
Things to note about Integrated Pharmaceuticals performance evaluation
Checking the ongoing alerts about Integrated Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integrated Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integrated Pharmaceuticals is not yet fully synchronised with the market data | |
| Integrated Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Integrated Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 35.4 K. Net Loss for the year was (1.83 M) with profit before overhead, payroll, taxes, and interest of 23 K. | |
| Integrated Pharmaceuticals currently holds about 180.85 K in cash with (1.1 M) of positive cash flow from operations. |
- Analyzing Integrated Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integrated Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Integrated Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integrated Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integrated Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integrated Pharmaceuticals' stock. These opinions can provide insight into Integrated Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Integrated Stock
If you are still planning to invest in Integrated Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Pharmaceuticals' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |